text: undertaken by the test provider, and responsibility for reporting medical issues; 
  
  (f) 
  
  they have an effective system of clinical governance in place which includes appropriate 
  standard operating procedures in relation to the carrying out of appropriate tests; 
  
  (g) a registered clinical scientist has oversight of clinical practices undertaken by the test 
  provider, and responsibility for reporting clinical issues; 
  
  (h) they have systems in place to identify any adverse incidents or quality control issues in 
  relation to appropriate tests and be able to report them as soon as reasonably practicable 
  to the Secretary of State; 
  
  (i) 
  
  they administer or provide an appropriate test to P, on or after the fifth day after the day 
  on which P arrived in England having received the information required by paragraph 
  4(b) and (c) (as appropriate); and 
  
  (j) 
  
  if they arrange with another person (“X”) for X to carry out any element of the single 
  end-to-end testing service on their behalf, the test provider ensures that X complies with 
  any of paragraphs (c) to (i) and 5(2), (3) and (5) as is relevant to the carrying out of that 
  element. 
  
  (2) For the purposes of sub-paragraph (1)— 
  
  (a) “point of care test” means a test processed outside a laboratory environment; 
  (b) “registered clinical scientist” means a person registered as a clinical scientist with the 
  Health and Care Professions Council pursuant to article 5 of the Health Professions Order 
  2001(**b**); 
  
  (c) “single end-to-end testing service” means a service which comprises accepting the 
  booking from the person to be tested, collecting and processing the sample to be tested, 
  carrying out genomic sequencing and providing the test result to P. 
  
  (3) For the purposes of sub-paragraph (1)(c) and (d), a person or laboratory (as the case may be) 
  meets the relevant requirements for accreditation to a standard where that person, or in the case of 
  a laboratory where the person who is the operator of the laboratory— 
  
  (a) has made a valid application for accreditation to UKAS (“stage one”); and 
  
  (b) complies with the requirements of sub-paragraph (4) where relevant. 
  
  (4) The requirements of this sub-paragraph are that— 
  
  (a) in the case of a person who completed stage one— 
  
  (i) before 15th December 2020 and who is carrying out a test after 18th January 2021, 
  (ii) on or after 15th December 2020 and who is carrying out a test after whichever is the 
  
  later of— 
  (aa) 18th January 2021, and 
  (bb)  the date four weeks after the date on which they completed stage one, 
  
  they have complied with the requirements published by UKAS in relation to accreditation 
  to that standard at http://www.ukas.com/C19-Stage2-UKAS-Appraisal (“stage two”), 
  
  (b) in the case of a person who completed stage two— 
  
  (i) on or before 18th January 2021 and who is carrying out a test on or after 1st July 
  
  2021, 
  
  (ii) after 18th January 2021 and who is carrying out a test on or after whichever is the 
  
  later of— 
  (aa) 1st July 2021, and 
  (bb)  the date four months after the date on which they completed stage two, 
  
  they are accredited by UKAS to that standard. 